13F-HR filed by Camber Capital Management LP
Camber Capital Management LP filed this 13F-HR for the quarter ended 2015-06-30, filed 2015-08-14, with 43 holding rows worth $1,468,727,000.
- Accession
- 0001546927-15-000225
- Filer
- CIK 1444043
- Filed
- 2015-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2015
A holdings report, 43 entries on the cover page, a total value of $1,468,727,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,468,727,000 with VALUE read as thousands by filing date, 13F file number 028-13745. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 1,750,000 | $103,425,000 | thousands by filing date | |
| SPY | 78462F103 | SHS | 500,000 | $102,925,000 | thousands by filing date | put |
| ASTRAZENECA PLC SPONSORED ADR | 046353108 | ADR | 1,250,000 | $79,638,000 | thousands by filing date | |
| Health Care Select Sector SPDR Fund | 81369Y209 | SHS | 1,000,000 | $74,390,000 | thousands by filing date | put |
| MASIMO CORP COM | 574795100 | Stock | 1,900,000 | $73,606,000 | thousands by filing date | |
| MEDICINES CO | 584688105 | COM | 2,500,000 | $71,525,000 | thousands by filing date | |
| EXPRESS SCRIPTS HLDG CO | 30219G108 | COM | 750,000 | $66,705,000 | thousands by filing date | |
| CYBERONICS | 23251P102 | COMMON STOCK | 1,000,000 | $59,460,000 | thousands by filing date | |
| GENOMIC HEALTH, INC. | 37244C101 | COM | 2,100,000 | $58,359,000 | thousands by filing date | |
| SELECT MED HLDGS CORP | 81619Q105 | COM | 3,500,000 | $56,700,000 | thousands by filing date | |
| UNIVERSAL AMERN CORP NEW | 91338E101 | COM | 5,234,898 | $52,977,000 | thousands by filing date | |
| NUVASIVE INC | 670704105 | COM | 1,100,000 | $52,118,000 | thousands by filing date | |
| ORTHOFIX INTL N V | N6748L102 | COM | 1,500,000 | $49,680,000 | thousands by filing date | |
| Johnson & Johnson | 478160104 | COM | 500,000 | $48,730,000 | thousands by filing date | call |
| CIGNA CORPORATION | 125509109 | COM | 300,000 | $48,600,000 | thousands by filing date | |
| LABORATORY CORP OF AMERICA | 50540R409 | COM NEW | 400,000 | $48,488,000 | thousands by filing date | |
| ARIAD PHARMACEUTICALS INC | 04033A100 | COM | 5,750,000 | $47,553,000 | thousands by filing date | |
| ARENA PHARMECEUTICALS INC | 040047102 | COMMON STOCK | 7,500,000 | $34,800,000 | thousands by filing date | |
| SEQUENOM INC COM NEW | 817337405 | COM | 9,000,000 | $27,360,000 | thousands by filing date | |
| DENTSPLY INTL INC | 249030107 | COM | 500,000 | $25,775,000 | thousands by filing date | |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 10,000,000 | $24,600,000 | thousands by filing date | |
| PERRIGO CO PLC SHS | G97822103 | Stock | 122,748 | $22,688,000 | thousands by filing date | |
| KINDRED HEALTHCARE INC | 494580103 | COM | 1,100,000 | $22,319,000 | thousands by filing date | |
| CROSS CTRY HEALTHCARE INC | 227483104 | COM | 1,493,765 | $18,941,000 | thousands by filing date | |
| NEKTAR THERAPEUTICS | 640268108 | COM | 1,500,000 | $18,765,000 | thousands by filing date | |
| QUEST DIAGNOSTICS INC COM | 74834L100 | Stock | 250,000 | $18,130,000 | thousands by filing date | |
| BIOSCRIP INC | 09069N108 | COM | 4,650,000 | $16,880,000 | thousands by filing date | |
| INNOCOLL AG | 47580Q103 | COM | 1,111,111 | $16,344,000 | thousands by filing date | |
| PROTALIX BIOTHERAPEUTICS INC | 74365A101 | COM | 7,274,577 | $14,185,000 | thousands by filing date | |
| VERACYTE INC COM | 92337F107 | Stock | 1,226,994 | $13,669,000 | thousands by filing date | |
| ANGIODYNAMICS INC | 03475V101 | COM | 735,383 | $12,060,000 | thousands by filing date | |
| DURECT CORP | 266605104 | COM | 5,000,000 | $11,950,000 | thousands by filing date | |
| CATABASIS PHARMACEUTICALS IN | 14875P107 | COM | 927,609 | $11,326,000 | thousands by filing date | |
| EPIRUS Biopharmaceuticals Inc | 29428P107 | Common Stock | 1,847,500 | $10,549,000 | thousands by filing date | |
| BIOLASE INC | 090911108 | COMMON STOCK | 5,332,394 | $9,278,000 | thousands by filing date | |
| GENMARK DIAGNOSTICS INC | 372309104 | COM | 1,017,897 | $9,222,000 | thousands by filing date | |
| INVITAE CORP | 46185L103 | COM | 500,000 | $7,440,000 | thousands by filing date | |
| ORASURE TECHNOLOGIES INC | 68554V108 | COM | 1,299,475 | $7,004,000 | thousands by filing date | |
| PROTALIX BIOTHERAPEUTICS INC | 74365AAB7 | NOTE 4.500% 9/1 | 9,000,000 | $6,960,000 | thousands by filing date | principal |
| KERYX BIOPHARMACEUTICALS | 492515101 | COMMON STOCK | 500,000 | $4,990,000 | thousands by filing date | |
| TARGACEPT INC | 87611R306 | COM | 1,560,000 | $4,352,000 | thousands by filing date | |
| CARDICA INC | 14141R101 | COM | 8,374,846 | $4,179,000 | thousands by filing date | |
| BIOLASE INC | 090911108 | COMMON STOCK | 1,841,173 | $82,000 | thousands by filing date | call |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001546927-15-000225 | this filing | 2015-08-14 | acceptance time not in the bulk data set |